Quanterix issued the following statement: Quanterix’s proposed acquisition of Akoya is the result of a rigorous and thorough Board evaluation consistent with its commitment to position the ...

Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six ratings firms that are covering the company, MarketBeat reports.